Cleared Traditional

iExaminer System with Panoptic Plus (K223381) - FDA 510(k) Clearance

Class II Ophthalmic device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2023
Decision
128d
Days
Class 2
Risk

K223381 is an FDA 510(k) clearance for the iExaminer System with Panoptic Plus. Classified as Camera, Ophthalmic, Ac-powered (product code HKI), Class II - Special Controls.

Submitted by Welch Allyn, Inc. (Skaneateles Falls, US). The FDA issued a Cleared decision on March 15, 2023 after a review of 128 days - within the typical 510(k) review window.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.1120 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.

View all Welch Allyn, Inc. devices

Submission Details

510(k) Number K223381 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 07, 2022
Decision Date March 15, 2023
Days to Decision 128 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
18d slower than avg
Panel avg: 110d · This submission: 128d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code HKI Camera, Ophthalmic, Ac-powered
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.1120
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HKI Camera, Ophthalmic, Ac-powered

All 33
Devices cleared under the same product code (HKI) and FDA review panel - the closest regulatory comparables to K223381.
Optina-4C (MHRC-C1N)
K231230 · Optina Diagnostics, Inc. · Dec 2023
Zilia Ocular FC (ZIL-10002)
K230627 · Zilia, Inc. · Nov 2023
Phoenix ICON, Phoenix ICON GO
K223575 · Neolight, LLC · Sep 2023
Eyer Retinal Camera NM-STD
K221329 · Phelcom Technologies · Feb 2023
Non-Mydriatic Retinal Camera NW500
K221111 · Topcon Corporation · Aug 2022
RetCam Envision
K203500 · Natus Medical Incorporated Dba Excel-Tech Ltd. (Xltek) · Apr 2021